Birch pollen allergy immunotherapy (LETI Pharma)

N/A

Report date: 2023/07/30 20:00:21

Base Information

Drug NameBirch pollen allergy immunotherapy (LETI Pharma)
Drug Alias NameDepigoid Birch-5000桦树花粉过敏免疫疗法 - LETI PharmaDepigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract,Depigoid Birch
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeti Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeti Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A